As of 2025-05-20, the Fair Value of Syndax Pharmaceuticals Inc (SNDX) is -19.25 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 9.30 USD, the upside of Syndax Pharmaceuticals Inc is -306.96%.
With the market price of 9.30 USD and our fair value calculation, Syndax Pharmaceuticals Inc (SNDX) is not a good investment. Investing in SNDX stocks now will result in a potential loss of 306.96%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -73.20 | 24.90 | -149.30 | -209.36 | -318.76 | -145.14 |
| YoY growth | -30.71% | 134.02% | -699.60% | -40.23% | -52.25% | -137.76% |
| Market Cap (mil) | 800.17 |
| P/E | |
| Forward P/E |
| EPS | -3.85 |
| Avg earnings growth rate | -137.76% |
| TTM earnings | -331.20 |